Acute Bronchitis-API Insights, 2014 st
On 21 November 2014
Summary The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing Process Validation: General Principles and Practices. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positioned them in a very strategic space in the global pharmaceutical supply chain, with a vast majority of the APIs and intermediates being sourced from markets such as India and China. Acute Bronchitis -API Insights, 2014 Report describes the current therapeutics that are propelling the pharmaceutical markets worldwide. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries related to the Acute Bronchitis. It also provides the India and China API Manufactures who are driving the current API Market. The report also highlights the patent and patent exclusivity information. The research analysis also presents the global sales forecasts data till 2015.
You can buy this Report @ http://www.jsbmarketresearch.com/healthcaremedical/r-acute-bronchitis-api-insights-2014-137912 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Data Sources The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts. Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope • A snapshot of the global Market therapeutics scenario for Acute Bronchitis. • A review of the marketed products under prescription for Acute Bronchitis, regulatory information and marketing status. • Coverage of global patent coverage and detailed commentaries on the US patent challenges. • Graphical representation of investigational products for patent expiry and market exclusivities across the globe. • Product profiles for marketed products for Acute Bronchitis with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details. • Coverage of API Manufacturers for Acute Bronchitis drugs in the United States, Europe and Asian Regions with location details. • Coverage of Regulatory filings in the US, Europe, and Asia specifically India and China for Acute Bronchitis drugs. • Key discontinued Marketed products. • Global Sales Figure from 2011-2015.
Reasons To Buy • Evaluate the marketing status and exclusivity details of Acute Bronchitis key products to exploit opportunities for generic drug development opportunities. • Key players in the pharmaceutical industry. •Strategic drivers and restraints of this market are revealed and market opportunities and Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
challenges are identified. • Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Acute Bronchitis. • API intelligence over marketed drugs for Acute Bronchitis and gaining primary intelligence over active ingredients manufacturers across the globe. • Uncovering opportunities in the rapidly growing the US markets.
Other industries we cover: • • • • • • • • •
Advertising and Media Automotive and Parts Consumer Goods Healthcare and Medical Finance and Banking Food and Beverages Travel and Tourism Textiles and Clothing SWOT Analysis
Discounts on Market Research Reports till 31st December, 2014 For more inquiries, contact at +91 - 998 729 5242 / contact@jsbmarketresearch.com
Table of Content • Indication Overview • Marketed Drugs Assessment • Marketed Details of Drugs by Application Type • Marketed Details of Drugs (NDA) by Marketing Status • Marketed Details of Drugs by Patent Expiration Timeline • The Active Pharmaceutical Ingredient (API) Manufacturers Assessment • The API Manufacturers by the United States Drug Master File (US DMF) Status • The API Manufacturers by the US DMF Status (Drug Specific) Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
• Drugs Market Data and Forecasted Sales Figures (2011-2015) • Marketed Drugs Information • Drugs Description • Global Active Pharmaceutical Manufacturers • Approval Status • Patent and Exclusivity Details • Company Overview • Discontinued Drugs Information
List Of Tables Acute Bronchitis Therapeutic Market, US, Marketed Drugs by Application Type, 2014 Acute Bronchitis Therapeutic Market, US, Marketed Drugs by Marketing Status, 2014 Acute Bronchitis Therapeutic Market, US, (Year), 2014 Acute Bronchitis Marketed Drugs, API Manufacturers by US DMF Status, 2014 Acute Bronchitis Marketed Drugs, US DMF Status Drug Specific (Number), 2014 Acute Bronchitis Therapeutic Market, Global Sales (in million USD), 2014 Acute Bronchitis Marketed Drugs, API Manufacturers, Global, 2014 Discontinued Drugs for Acute Bronchitis, 2014
List Of Figures Acute Bronchitis Therapeutic Market, US, Marketed Drugs by Application Type (%), 2014 Acute Bronchitis Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2014 Acute Bronchitis Therapeutic Market, US, (Year), 2014 Acute Bronchitis Marketed Drugs, API Manufacturers by US DMF Status (%), 2014 Acute Bronchitis Marketed Drugs, US DMF Status Drug Specific (Number), 2014 Acute Bronchitis Therapeutic Market, Global Sales (in million USD), 2014 Acute Bronchitis Marketed Drugs, Patent/Exclusivity Expiry (Year), 2014
Report Price: Licence Type
Price
$ 1250
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Site Licence
$ 2500
Enterprise Wide Licence
$ 4000
Related Reports: Remodulin-API Insights, 2014 Herpes Labialis (Oral Herpes)-API Insights, 2014 Nebivololo Mylan-API Insights, 2014 TetraLogic Pharmaceuticals - Product Pipeline Review - 2014 Otonomy, Inc. - Product Pipeline Review - 2014 Anchor Therapeutics, Inc. - Product Pipeline Review - 2014 Ascepion Pharmaceuticals, Inc. - Product Pipeline Review - 2014 Laila Pharmaceuticals Pvt. Ltd. - Product Pipeline Review - 2014 Paras Biopharmaceuticals Finland Oy - Product Pipeline Review - 2014 iBio, Inc. - Product Pipeline Review - 2014
You can order this report by calling on +91 - 998 7295 242 or mail us your contact details at contact@jsbmarketresearch.com About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along with providing in-depth analysis though reports, JSB market research also provides regular updates of the market though newsletters. Our reports are a well-researched work of market researchers with an extensive knowledge and a good level of market experience.
To know more on Acute Bronchitis-API Insights, 2014 http://www.jsbmarketresearch.com/healthcare-medical/r-acute-bronchitis-apiinsights-2014-137912 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/